BILLERICA, Mass.—MilliporeSigma and PCAS S.A. have joined forces in an agreement to expand MilliporeSigma’s excipients portfolio. Though no financial details were disclosed, the agreement stipulates that MilliporeSigma will be the exclusive global distributor of the Expansorb line of biocompatible and biodegradable polymers. This portfolio includes 38 polymers for sustained release of small-molecule and selected peptide injectables. The Expansorb PLA and PLGA polymers are manufactured by PCAS under cGMP conditions and will be sold under MilliporeSigma’s Emprove program once the appropriate evaluations and certifications are complete.